MAP3K13 Antibody

ArtNr	CSB-PA013421LA01HU-50ug
Hersteller	Cusabio
Menge	50 ug
Quantity options	100 ug 20 ug 50 ug
Kategorie	Oncology Antibodies By Cell Type Blastoma Carcinoma Glioma Hematology Lymphoma Myeloma Melanoma Sarcoma Immunohistochemistry Western Blot ELISA Primary Antibodies By Organ Bladder Cancer Immunostaining
Typ	Antibody Polyclonal
Format	Liquid
Applikationen	WB, IHC, ELISA
Specific against	Human (Homo sapiens), Mouse (Murine, Mus musculus), Rat (Rattus norvegicus)
Host	Rabbit
Isotype	IgG
Konjugat/Tag	Unconjugated
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	EC 2.7.11.25 antibody,Leucine zipper bearing kinase antibody,Leucine zipper-bearing kinase antibody,LZK antibody,M3K13_HUMAN antibody,MAP3K13 antibody,MEKK13 antibody,MGC133196 antibody,Mitogen activated protein kinase kinase kinase 13 antibody,Mitogen-activated protein kinase kinase kinase 13 antibody,Mixed lineage kinase antibody,MLK antibody,OTTHUMP00000210397 antibody
Similar products	MAP3K13, LZK, Mitogen-activated protein kinase kinase kinase 13 (EC 2.7.11.25) (Leucine zipper-bearing kinase) (Mixed lineage kinase) (MLK)
Lieferbar
Manufacturer - Type	Polyclonal Antibody
Manufacturer - Applications	ELISA, WB, IHC; Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200
Manufacturer - Targets	MAP3K13
Storage Conditions	Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Manufacturer - Alias	EC 2.7.11.25 antibody, Leucine zipper bearing kinase antibody, Leucine zipper-bearing kinase antibody, LZK antibody, M3K13_HUMAN antibody, MAP3K13 antibody, MEKK13 antibody, MGC133196 antibody, Mitogen activated protein kinase kinase kinase 13 antibody, Mitogen-activated protein kinase kinase kinase 13 antibody, Mixed lineage kinase antibody, MLK antibody, OTTHUMP00000210397 antibody
Immunogen Species	Human
Immunogen	Recombinant Human Mitogen-activated protein kinase kinase kinase 13 protein (506-835AA)
Dilution	ELISA:1:2000-1:10000 WB:1:500-1:5000 IHC:1:20-1:200
Background	Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B.
Buffer	Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Purification Method	>95%, Protein G purified
General Research Areas	Signal Transduction
Initial Research Areas	Signal Transduction
Antigen Species	Human
Antigen	Recombinant Human Mitogen-activated protein kinase kinase kinase 13 protein (506-835AA)
Clonality	Polyclonal

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

CSB-PA013421LA01HU-50ug-datasheet.pdf

Sicherheitsdatenblatt anfordern

Einfache Bestellung Periodische Bestellung

Menge: 50 ug

lieferbar

Lieferung vsl. bis 25.12.2025

Express-Lieferung: 3 Tage sparen

Vergleichen

Auf den Wunschzettel

Angebot anfordern